Role of AT1-receptor Blockers in Insulin-induced Vasodilation.

NCT00742066 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Insulin Resistance
Microcirculation

Interventions

DRUG: Irbesartan
DRUG: Felodipine
DRUG: Placebo

Sponsor

Maastricht University Medical Center